# The ATP Project (Antipsychotic-TEP-Psychosis)

> **NCT06651112** · — · NOT_YET_RECRUITING · sponsor: **Université de Sherbrooke** · enrollment: 18 (estimated)

## Conditions studied

- First Episose Psychosis
- Metabolic Disease
- Psychosis; Episode

## Interventions

- **DRUG:** Antipsychotic drugs

## Key facts

- **NCT ID:** NCT06651112
- **Lead sponsor:** Université de Sherbrooke
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-11-01
- **Primary completion:** 2026-11-01
- **Final completion:** 2027-06-01
- **Target enrollment:** 18 (ESTIMATED)
- **Last updated:** 2024-11-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06651112

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06651112, "The ATP Project (Antipsychotic-TEP-Psychosis)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT06651112. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*